Hybio Pharmaceutical Market Cap

Hybio Pharmaceutical has a market cap or net worth of 14.35 billion as of June 27, 2025. Its market cap has increased by 31.79% in one year.

Market Cap

14.35B

Enterprise Value

16.09B

Revenue

749.91M

Ranking

n/a

PE Ratio

n/a

Stock Price

16.26

Market Cap Chart

Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 14.35B, an increase of 389.85%. That is a compound annual growth rate of 11.81%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	14.35B	26.07%
Dec 31, 2024	11.38B	-5.08%
Dec 29, 2023	11.99B	-22.75%
Dec 30, 2022	15.53B	39.41%
Dec 31, 2021	11.14B	88.22%
Dec 31, 2020	5.92B	14.66%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	344.23B
Shenzhen Mindray Bio-Medical Electronics	274.10B
WuXi AppTec	189.12B
Zhangzhou Pientzehuang Pharmaceutical.,	120.95B
Sichuan Biokin Pharmaceutical	119.25B
Aier Eye Hospital Group	115.27B
Shanghai United Imaging Healthcare	105.13B
Yunnan Baiyao Group Co.,Ltd	98.63B

Market Cap Rankings